Terms: = Head and neck cancer AND XPA, XPAC, 7507, ENSG00000136936, XP1, P23025 AND Diagnosis
4 results:
1. The DNA damage response network in the treatment of head and neck squamous cell carcinoma.
Psyrri A; Gkotzamanidou M; Papaxoinis G; Krikoni L; Economopoulou P; Kotsantis I; Anastasiou M; Souliotis VL
ESMO Open; 2021 Apr; 6(2):100075. PubMed ID: 33714009
[TBL] [Abstract] [Full Text] [Related]
2. The survival impact of xpa and XPC genetic polymorphisms on patients with esophageal squamous cell carcinoma.
Yang PW; Hsieh CY; Kuo FT; Huang PM; Hsu HH; Kuo SW; Chen JS; Lee JM
Ann Surg Oncol; 2013 Feb; 20(2):562-71. PubMed ID: 22941172
[TBL] [Abstract] [Full Text] [Related]
3. Association of FANCC and PTCH1 with the development of early dysplastic lesions of the head and neck.
Ghosh A; Ghosh S; Maiti GP; Mukherjee S; Mukherjee N; Chakraborty J; Roy A; Roychoudhury S; Panda CK
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S528-38. PubMed ID: 21861228
[TBL] [Abstract] [Full Text] [Related]
4. The association of sequence variants in DNA repair and cell cycle genes with cancers of the upper aerodigestive tract.
Hall J; Hashibe M; Boffetta P; Gaborieau V; Moullan N; Chabrier A; Zaridze D; Shangina O; Szeszenia-Dabrowska N; Mates D; Janout V; Fabiánová E; Holcatova I; Hung RJ; McKay J; Canzian F; Brennan P
Carcinogenesis; 2007 Mar; 28(3):665-71. PubMed ID: 17040931
[TBL] [Abstract] [Full Text] [Related]
